The authors reply: Perioperative Durvalumab for Resectable Non Small-Cell Lung Cancer

John V. Heymach; David Harpole; Martin Reck

doi:10.1056/NEJMc2313778

The authors reply: Perioperative Durvalumab for Resectable Non Small-Cell Lung Cancer

John V. Heymach, David Harpole, Martin Reck

Thoracic Head & Neck Medical Oncology

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	287-288
Number of pages	2
Journal	New England Journal of Medicine
Volume	390
Issue number	3
DOIs	https://doi.org/10.1056/NEJMc2313778
State	Published - Jan 18 2024

ASJC Scopus subject areas

General Medicine

Access to Document

10.1056/NEJMc2313778

Cite this

@article{debf736fefbe423fad10ded575103c67,

title = "The authors reply: Perioperative Durvalumab for Resectable Non Small-Cell Lung Cancer",

author = "Heymach, {John V.} and David Harpole and Martin Reck",

year = "2024",

month = jan,

day = "18",

doi = "10.1056/NEJMc2313778",

language = "English (US)",

volume = "390",

pages = "287--288",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "3",

}

TY - JOUR

T1 - The authors reply

T2 - Perioperative Durvalumab for Resectable Non Small-Cell Lung Cancer

AU - Heymach, John V.

AU - Harpole, David

AU - Reck, Martin

PY - 2024/1/18

Y1 - 2024/1/18

UR - http://www.scopus.com/inward/record.url?scp=85182955274&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85182955274&partnerID=8YFLogxK

U2 - 10.1056/NEJMc2313778

DO - 10.1056/NEJMc2313778

M3 - Letter

C2 - 38231635

AN - SCOPUS:85182955274

SN - 0028-4793

VL - 390

SP - 287

EP - 288

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 3

ER -

The authors reply: Perioperative Durvalumab for Resectable Non Small-Cell Lung Cancer

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this